Targeted News Service

FLUMIST QUADRIVALENT Vaccine Now Available in the US for 2023-2024 Flu Season
September 06, 2023

WILMINGTON, Delaware, Sept. 6 (TNSres) -- AstraZeneca, a biopharmaceutical company, issued the following news release on Sept. 5, 2023:

AstraZeneca today announced FLUMIST QUADRIVALENT (Influenza Vaccine Live, Intranasal) doses are now available in the US for the 2023-2024 influenza season. FLUMIST QUADRIVALENT, the only Food and Drug Administration (FDA)-approved needle-free, nasal-spray flu vaccine, is indicated for people 2 through 49 years old. 1,2

While some people . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form